Freedom Capital sets USD 36.00 target for HealthStream stock

Published on 10/20/2026 at 18:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 83.73 million, up 12.50 percent year over year. HealthStream stock costs EUR 30.10 on October 20, 2026 at 6:45 p.m. CEST.

Analyst target and results

Freedom Capital initiated coverage with a USD 36.00 target on October 13, 2026.
Second-quarter 2026 revenue reached USD 83.73 million, up 12.50 percent year over year.
HealthStream stock costs EUR 30.10 at Lang & Schwarz on October 20, 2026 at 6:45 p.m. CEST.

HSTM, US42222N1037, Illustration mit AI erstellt.

Freedom Capital initiated coverage of HealthStream with a Hold rating and a USD 36.00 price target on October 13, 2026, according to Markets Insider. The firm cited accelerating growth and valuation in its assessment. HealthStream stock was trading at EUR 30.10 at Lang & Schwarz on October 20, 2026 at 6:45 p.m. CEST.

Revenue growth sets the tone

HealthStream reported second-quarter 2026 revenue of USD 83.73 million, an increase of 12.50 percent from the same quarter a year earlier. The figure also exceeded the USD 80.82 million consensus estimate, while adjusted earnings per share reached USD 0.23 against USD 0.17 expected, according to Investing.com. The report also identified a one-time accounting catch-up item alongside stronger subscription sales.

Valuation remains the counterweight

HealthStream's latest reported quarter combined growth with a valuation that keeps analyst expectations important. MarketBeat reported a consensus Hold rating and a USD 27.00 average price target on October 17, 2026, while Freedom Capital's USD 36.00 target offered a higher reference point. MarketBeat also listed a USD 19.50 to USD 34.48 12-month range, a USD 968.1 million market capitalization and a 46.01 price-to-earnings ratio on that date.

HealthStream's market position

HealthStream provides workforce and provider solutions for healthcare organizations, including learning, training, scheduling, credentialing and performance-management software. The company describes its business as serving healthcare organizations across the United States through a unified suite of solutions on its investor-relations page.

What the target means

The USD 36.00 target sits above the USD 27.00 consensus target, showing a wide spread in published expectations. That gap matters because the second-quarter revenue increase of 12.50 percent came with a price-to-earnings ratio of 46.01, placing growth and valuation side by side in the current assessment.

Stock price and investor view

The euro quotation gives German investors a current trading reference, while the Nasdaq listing remains the company's primary U.S. market. HealthStream's current price, recent quarterly growth and differing analyst targets provide the main factual markers for assessing the stock's position.

The further course of trading is shown by the continuously updated real-time quote of HealthStream stock.